Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- PMID: 33329607
- PMCID: PMC7733922
- DOI: 10.3389/fimmu.2020.611337
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
Abstract
The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS-CoV-2 initially infects the upper respiratory tract, its first interactions with the immune system must occur predominantly at the respiratory mucosal surfaces, during both inductive and effector phases of the response. However, almost all studies of the immune response in COVID-19 have focused exclusively on serum antibodies and systemic cell-mediated immunity including innate responses. This article proposes that there is a significant role for mucosal immunity and for secretory as well as circulating IgA antibodies in COVID-19, and that it is important to elucidate this in order to comprehend especially the asymptomatic and mild states of the infection, which appear to account for the majority of cases. Moreover, it is possible that mucosal immunity can be exploited for beneficial diagnostic, therapeutic, or prophylactic purposes.
Keywords: COVID-19; SARS-CoV-2; immune response; immunoglobulin A; mucosal immunity.
Copyright © 2020 Russell, Moldoveanu, Ogra and Mestecky.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Mucosal immunity in COVID-19: a comprehensive review.Front Immunol. 2024 Aug 14;15:1433452. doi: 10.3389/fimmu.2024.1433452. eCollection 2024. Front Immunol. 2024. PMID: 39206184 Free PMC article. Review.
-
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.Curr Opin Infect Dis. 2021 Jun 1;34(3):181-186. doi: 10.1097/QCO.0000000000000724. Curr Opin Infect Dis. 2021. PMID: 33899752 Review.
-
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.Front Immunol. 2020 Dec 16;11:610300. doi: 10.3389/fimmu.2020.610300. eCollection 2020. Front Immunol. 2020. PMID: 33391280 Free PMC article. Clinical Trial.
-
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.EBioMedicine. 2023 Dec;98:104893. doi: 10.1016/j.ebiom.2023.104893. Epub 2023 Nov 29. EBioMedicine. 2023. PMID: 38035462 Free PMC article.
-
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.J Immunol Methods. 2021 Feb;489:112937. doi: 10.1016/j.jim.2020.112937. Epub 2020 Nov 28. J Immunol Methods. 2021. PMID: 33253698 Free PMC article.
Cited by
-
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.Allergy. 2022 Aug;77(8):2446-2458. doi: 10.1111/all.15311. Epub 2022 Apr 15. Allergy. 2022. PMID: 35403221 Free PMC article.
-
A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.PLoS One. 2023 Jan 20;18(1):e0277505. doi: 10.1371/journal.pone.0277505. eCollection 2023. PLoS One. 2023. PMID: 36662784 Free PMC article.
-
A proteomic perspective and involvement of cytokines in SARS-CoV-2 infection.PLoS One. 2023 Jan 6;18(1):e0279998. doi: 10.1371/journal.pone.0279998. eCollection 2023. PLoS One. 2023. PMID: 36608055 Free PMC article.
-
Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus.Microbiol Immunol. 2022 Aug;66(8):403-410. doi: 10.1111/1348-0421.13011. Epub 2022 Jun 16. Microbiol Immunol. 2022. PMID: 35607844 Free PMC article.
-
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.Front Immunol. 2021 Oct 12;12:744887. doi: 10.3389/fimmu.2021.744887. eCollection 2021. Front Immunol. 2021. PMID: 34712232 Free PMC article.
References
-
- Bermejo-Martin JF, Gonzalez-Rivera M, Almansa R, Micheloud D, Dominguez-Gil M, Resino S, et al. SARS-CoV-2 RNA viremia is associated with a sepsis-like host response and critical illness in COVID-19. medRxiv (2020) 2020.08.25.20154252. 10.1101/2020.08.25.20154252 - DOI
-
- Russell MW, Mestecky J, Strober W, Kelsall BL, Lambrecht BN, Cheroutre H. The mucosal immune system: Overview. In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN, editors. Mucosal Immunology, 4 Amsterdam: Academic Press/Elsevier; (2015). p. 3–8.
-
- Russell MW. Biological functions of IgA. In: Kaetzel CS, editor. Mucosal Immune Defense: Immunoglobulin A. New York: Springer; (2007). p. 144–72.
-
- Woof JM, Mestecky J. Mucosal immunoglobulins. In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN, editors. In: Mucosal Immunology, 4 Amsterdam: Academic Press/Elsevier; (2015). p. 287–324.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous